BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8535907)

  • 1. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.
    Buzdar AU; Singletary SE; Booser DJ; Frye DK; Wasaff B; Hortobagyi GN
    Surg Oncol Clin N Am; 1995 Oct; 4(4):715-34. PubMed ID: 8535907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
    Ueno NT; Buzdar AU; Singletary SE; Ames FC; McNeese MD; Holmes FA; Theriault RL; Strom EA; Wasaff BJ; Asmar L; Frye D; Hortobagyi GN
    Cancer Chemother Pharmacol; 1997; 40(4):321-9. PubMed ID: 9225950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.
    Low JA; Berman AW; Steinberg SM; Danforth DN; Lippman ME; Swain SM
    J Clin Oncol; 2004 Oct; 22(20):4067-74. PubMed ID: 15483018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
    Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immediate results of the combined treatment of stage-III breast cancer].
    Muratkhodzhaev NK; Letiagin VP; Khodzhaev AV
    Vopr Onkol; 1990; 36(10):1227-31. PubMed ID: 2174591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-center experience with inflammatory breast cancer, 1985-2003.
    Smoot RL; Koch CA; Degnim AC; Sterioff S; Donohue JH; Grant CS; Barnes SA; Gullerud RE; Hobday TJ; Farley DR
    Arch Surg; 2006 Jun; 141(6):567-72; discussion 572-3. PubMed ID: 16785357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
    Hohaus S; Funk L; Martin S; Schlenk RF; Abdallah A; Hahn U; Egerer G; Goldschmidt H; Schneeweiss A; Fersis N; Kaul S; Wallwiener D; Bastert G; Haas R
    Br J Cancer; 1999 Mar; 79(9-10):1500-7. PubMed ID: 10188897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term effect on preoperative ulnaris arterial intubation chemotherapy in treatment of stage III breast cancer].
    Huang C; Zhang X; Lu H; Wu X; Guan G; Wang C; Zhou Y; Zhang J
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):412-4. PubMed ID: 11832070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
    Somlo G; Frankel P; Chow W; Leong L; Margolin K; Morgan R; Shibata S; Chu P; Forman S; Lim D; Twardowski P; Weitzel J; Alvarnas J; Kogut N; Schriber J; Fermin E; Yen Y; Damon L; Doroshow JH
    J Clin Oncol; 2004 May; 22(10):1839-48. PubMed ID: 15143076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB; Liu L; Yashar J; Glicksman AS
    J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.
    Schwartzberg L; Weaver C; Lewkow L; McAneny B; Zhen B; Birch R; West W; Tauer K; Buckner C
    Bone Marrow Transplant; 1999 Nov; 24(9):981-7. PubMed ID: 10556957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.
    Bitran JD; Samuels B; Trujillo Y; Klein L; Schroeder L; Martinec J
    Clin Cancer Res; 1996 Sep; 2(9):1509-13. PubMed ID: 9816327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
    Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
    Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
    Chen AM; Meric-Bernstam F; Hunt KK; Thames HD; Oswald MJ; Outlaw ED; Strom EA; McNeese MD; Kuerer HM; Ross MI; Singletary SE; Ames FC; Feig BW; Sahin AA; Perkins GH; Schechter NR; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Jun; 22(12):2303-12. PubMed ID: 15197191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.